Phase 0 Microdose Study

Clinical trial NCT00975936 · COMPLETED

Trial details

NCT number: NCT00975936
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Autoimmune Diseases

Start date: 2009-09-21
Primary completion: 2009-11-12
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.